Helicobacter pylori enhances CIP2A expression and cell proliferation via JNK2/ATF2 signaling in human gastric cancer cells

International Journal of Molecular Medicine

Volumn 33, Issue 3, 2014, Pages 703-710

  Zhao, Yongxun ^a   Li, Yumin ^a   Han, Jian ^a   Liu, Tao ^a   Guan, Quanlin ^a   Zhao, Peng ^a   Guo, Lingyun ^a   Liu, Kaikun ^a   He, Dongqiang ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

CIP2A; Gastric cancer; Helicobacter pylori; JNK2; Proliferation; RNA interference

Indexed keywords

AUTOANTIGENS; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MEMBRANE PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE 9; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS;

EID: 84893874777     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.1615     Document Type: Article

References (39)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Konturek PC, Konturek SJ and Brzozowski T: Helicobacter pylori infection in gastric cancerogenesis. J Physiol Pharmacol 60: 3-21, 2009.
3. Polk DB and Peek RM Jr: Helicobacter pylori: Gastric cancer and beyond. Nat Rev Cancer 10: 403-414, 2010.
4. Ding SZ, Smith MF Jr and Goldberg JB: Helicobacter pylori and mitogen-activated protein kinases regulate the cell cycle, proliferation and apoptosis in gastric epithelial cells. J Gastroenterol Hepatol 23: E67-e78, 2008.
5. Chen YC, Wang Y, Li JY, Xu WR and Zhang YL: H. pylori stimulates proliferation of gastric cancer cells through activating mitogen-activated protein kinase cascade. World J Gastroenterol 12: 5972-5977, 2006.
6. Johnson GL and Lapadat R: Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298: 1911-1912, 2002.
7. Chang L and Karin M: Mammalian MAP kinase signalling cascades. Nature 410: 37-40, 2001.
8. Brandt S, Kwok T, Hartig R, König W and Backert S: NF-kappaB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. Proc Natl Acad Sci USA 102: 9300-9305, 2005.
9. Li Q, Liu N, Shen B, et al: Helicobacter pylori enhances cyclooxygenase 2 expression via p38MAPK/ATF-2 signaling pathway in MKN45 cells. Cancer Lett 278: 97-103, 2009.
10. Wang G, Gao F, Zhang W, et al: Involvement of Aquaporin 3 in Helicobacter pylori-related gastric diseases. PLoS One 7: E49104, 2012.
11. de Paulis A, Prevete N, Rossi FW, et al: Helicobacter pylori Hp(2-20) promotes migration and proliferation of gastric epithelial cells by interacting with formyl peptide receptors in vitro and accelerates gastric mucosal healing in vivo. J Immunol 183: 3761-3769, 2009.
12. Nagy TA, Wroblewski LE, Wang D, et al: β-Catenin and p120 mediate PPARd-dependent proliferation induced by Helicobacter pylori in human and rodent epithelia. Gastroenterology 141: 553-564, 2011.
13. Zhao D, Liu Z, Ding J, et al: Helicobacter pylori CagA upregulation of CIP2A is dependent on the Src and MEK/ERK pathways. J Med Microbiol 59: 259-265, 2009.
14. Seshacharyulu P, Pandey P, Datta K and Batra SK: Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancer. Cancer Lett 335: 9-18, 2013.
15. Junttila MR, Puustinen P, Niemelä M, et al: CIP2A inhibits PP2A in human malignancies. Cell 130: 51-62, 2007.
16. Li W, Ge Z, Liu C, et al: CIP2A is overexpressed in gastric cancer and its depletion leads to impaired clonogenicity, senescence, or differentiation of tumor cells. Clin Cancer Res 14: 3722-3728, 2008.
17. Khanna A, Böckelman C, Hemmes A, et al: MYC-dependent regulation and prognostic role of CIP2A in gastric cancer. J Natl Cancer Inst 101: 793-805, 2009.
18. Mathiasen DP, Egebjerg C, Andersen SH, et al: Identification of a c-Jun N-terminal kinase-2-dependent signal amplification cascade that regulates c-Myc levels in ras transformation. Oncogene 31: 390-401, 2011.
19. Wandler AM and Guillemin K: Transgenic expression of the Helicobacter pylori virulence factor CagA promotes apoptosis or tumorigenesis through JNK activation in Drosophila. PLoS Pathog 8: E1002939, 2012.
20. Thun MJ, DeLancey JO, Center MM, Jemal A and Ward EM: The global burden of cancer: Priorities for prevention. Carcinogenesis 31: 100-110, 2010.
21. Fock KM and Ang TL: Epidemiology of Helicobacter pylori infection and gastric cancer in Asia. J Gastroenterol Hepatol 25: 479-486, 2010.
22. Zhang DH, Zhou LY, Lin SR, et al: Recent changes in the prevalence of Helicobacter pylori infection among children and adults in high-or low-incidence regions of gastric cancer in China. Chin Med J (Engl) 122: 1759-1763, 2009.
23. Wang XQ, Yan H, Terry PD, et al: Interaction between dietary factors and Helicobacter pylori infection in noncardia gastric cancer: A population-based case-control study in China. J Am Coll Nutr 31: 375-384, 2012.
24. Zhang Y, Sun LP, Xing CZ, et al: Interaction between GSTP1 Val allele and H. pylori infection, smoking and alcohol consumption and risk of gastric cancer among the Chinese population. PLoS One 7: E47178, 2012.
25. Epplein M, Zheng W, Xiang YB, et al: Prospective study of Helicobacter pylori biomarkers for gastric cancer risk among Chinese men. Cancer Epidemiol Biomarkers Prev 21: 2185-2192, 2012.
26. Fukase K, Kato M, Kikuchi S, et al: Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: An open-label, randomised controlled trial. Lancet 372: 392-397, 2008.
27. Fuccio L, Zagari RM, Eusebi LH, et al: Meta-analysis: Can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann Intern Med 151: 121-128, 2009.
28. Jang SH, Lim JW and Kim H: Beta-carotene inhibits Helicobacter pylori-induced expression of inducible nitric oxide synthase and cyclooxygenase-2 in human gastric epithelial AGS cells. J Physiol Pharmacol 60 (Suppl 7): S131-S137, 2009.
29. Lim JW and Kim H: Role of protease-activated receptor-2 on cell death and DNA fragmentation in Helicobacter pylori-infected gastric epithelial cells. J Transl Med 8: 85, 2010.
30. Zhao C, Ma H, Bu X, Wang W and Zhang N: SFRP5 inhibits gastric epithelial cell migration induced by macrophage-derived Wnt5a. Carcinogenesis 34: 146-152, 2013.
31. Zhong J, Zhao M, Luo Q, et al: CCDC134 is down-regulated in gastric cancer and its silencing promotes cell migration and invasion of GES-1 and AGS cells via the MAPK pathway. Mol Cell Biochem 372: 1-8, 2013.
32. Choi IJ, Fujimoto S, Yamauchi K, Graham DY and Yamaoka Y: Helicobacter pylori environmental interactions: Effect of acidic conditions on H. pylori-induced gastric mucosal interleukin-8 production. Cell Microbiol 9: 2457-2469, 2007.
33. Ding S-Z, Olekhnovich IN, Cover TL, Peek RM Jr, Smith MF Jr and Goldberg JB: Helicobacter pylori and mitogen-activated protein kinases mediate activator protein-1 (AP-1) subcomponent protein expression and DNA-binding activity in gastric epithelial cells. FEMS Immunol Med Microbiol 53: 385-394, 2008.
34. Matsumoto A, Isomoto H, Nakayama M, et al: Helicobacter pylori VacA reduces the cellular expression of STAT3 and pro-survival Bcl-2 family proteins, Bcl-2 and Bcl-XL, leading to apoptosis in gastric epithelial cells. Dig Dis Sci 56: 999-1006, 2011.
35. Ke H, Harris R, Coloff JL, et al: The c-Jun NH2-terminal kinase 2 plays a dominant role in human epidermal neoplasia. Cancer Res 70: 3080-3088, 2010.
36. Cellurale C, Sabio G, Kennedy NJ, et al: Requirement of c-Jun NH(2)-terminal kinase for Ras-initiated tumor formation. Mol Cell Biol 31: 1565-1576, 2011.
37. Li N, Han L, Chen J, Lin X, Chen H and She F: Proliferative and apoptotic effects of gastric epithelial cells induced by coccoidHelicobacter pylori. J Basic Microbiol 53: 147-155, 2013.
38. Feng Y, Wang L, Zeng J, et al: FoxM1 is overexpressed in Helicobacter pylori-induced gastric carcinogenesis and is nega-tively regulated by miR-370. Mol Cancer Res 11: 834-844, 2013.
39. Himaya SWA, Dewapriya P and Kim SK: EGFR tyrosine kinase inhibitory peptide attenuates Helicobacter pylori-mediated hyper-proliferation in AGS enteric epithelial cells. Toxicol Appl Pharmacol 269: 205-214, 2013.